• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四价钒与人转铁蛋白的结合:与二氯二茂钒抗癌活性的潜在关联。

Binding of V(IV) to human transferrin: potential relevance to anticancer activity of vanadocene dichloride.

作者信息

Du Hongyan, Xiang Junfeng, Zhang Yazhou, Tang Yalin, Xu Guangzhi

机构信息

Beijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Center for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China.

出版信息

J Inorg Biochem. 2008 Jan;102(1):146-9. doi: 10.1016/j.jinorgbio.2007.07.030. Epub 2007 Aug 6.

DOI:10.1016/j.jinorgbio.2007.07.030
PMID:17825420
Abstract

The action mechanism of vanadocene dichloride, Cp2VCl2 (Cp=eta5-C5H5), has been investigated by interaction with human serum transferrin for its promising antitumor activities. Our results have shown that Cp2VCl2 binds to transferrin and form a new complex, and the calculated apparent association constant is 1.37 x 10(5)M(-1) from the fluorescence quenching. Simultaneously, the variation of the secondary structure of transferrin occurs, most probably due to the coordination of the amino residues of protein with VIV. It was evidenced that Cp is released free in solution after VIV binding to transferrin by 1H NMR measurements. These results have shown that Cp2VCl2 forms a complex with transferrin, which may provide a possible pathway in the transport and targeted delivery of the antitumor agent.

摘要

二氯茂钒(Cp2VCl2,Cp = η5-C5H5)因其具有前景的抗肿瘤活性,已通过与人血清转铁蛋白相互作用对其作用机制进行了研究。我们的结果表明,Cp2VCl2与转铁蛋白结合形成一种新的复合物,通过荧光猝灭计算得到的表观缔合常数为1.37×10(5)M(-1)。同时,转铁蛋白的二级结构发生变化,最有可能是由于蛋白质的氨基残基与四价钒配位所致。通过1H NMR测量证明,四价钒与转铁蛋白结合后,Cp在溶液中游离释放。这些结果表明,Cp2VCl2与转铁蛋白形成复合物,这可能为抗肿瘤药物的运输和靶向递送提供一条可能的途径。

相似文献

1
Binding of V(IV) to human transferrin: potential relevance to anticancer activity of vanadocene dichloride.四价钒与人转铁蛋白的结合:与二氯二茂钒抗癌活性的潜在关联。
J Inorg Biochem. 2008 Jan;102(1):146-9. doi: 10.1016/j.jinorgbio.2007.07.030. Epub 2007 Aug 6.
2
Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.构建盐酸阿霉素和二氯二茂钒靶向转铁蛋白受体的药物传递系统。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5982-6. doi: 10.1016/j.bmcl.2011.07.066. Epub 2011 Jul 26.
3
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.血清蛋白与双(麦芽醇)氧钒(IV)相互作用的新见解:胰岛素增强型钒药物的转运与生物转化
J Am Chem Soc. 2005 Apr 13;127(14):5104-15. doi: 10.1021/ja043944n.
4
Mechanism of formation of the complex between transferrin and bismuth, and interaction with transferrin receptor 1.转铁蛋白与铋形成复合物的机制及其与转铁蛋白受体1的相互作用。
Biochemistry. 2004 Nov 23;43(46):14722-31. doi: 10.1021/bi048484p.
5
Calorimetric, spectroscopic, and model studies provide insight into the transport of Ti(IV) by human serum transferrin.量热法、光谱法和模型研究为了解人血清转铁蛋白对Ti(IV)的转运提供了线索。
J Am Chem Soc. 2007 Mar 21;129(11):3444-54. doi: 10.1021/ja068149j. Epub 2007 Feb 22.
6
Investigation of vanadocene(IV) alpha-amino acid complexes: synthesis, structure, and behavior in physiological solutions, human plasma, and blood.二茂钒(IV)α-氨基酸配合物的研究:在生理溶液、人血浆和血液中的合成、结构及行为
Inorg Chem. 2006 Mar 6;45(5):2156-62. doi: 10.1021/ic050687u.
7
Contrasting synergistic anion effects in vanadium(V) binding to nicatransferrin versus human serum transferrin.钒(V)与尼克酞基转移蛋白和人血清转铁蛋白结合的协同阴离子效应的对比。
Biochemistry. 2009 Dec 15;48(49):11609-11. doi: 10.1021/bi901630j.
8
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride.潜在抗肿瘤剂二氯二茂钒的生物相关反应。
Metallomics. 2016 May 1;8(5):532-41. doi: 10.1039/c6mt00002a.
9
Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.人血清转铁蛋白对Ti(IV)的摄取与释放以及癌细胞对Ti(IV)-转铁蛋白的识别:了解抗癌药物二氯二茂钛的作用机制
Biochemistry. 2000 Aug 22;39(33):10023-33. doi: 10.1021/bi000798z.
10
New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum.血清中胰岛素增强型钒化合物生物转化和转运的理解新进展。
Inorg Chem. 2010 Jan 4;49(1):174-87. doi: 10.1021/ic9017213.

引用本文的文献

1
Exploring the coordination chemistry of ruthenium complexes with lysozymes: structural and in-solution studies.探索钌配合物与溶菌酶的配位化学:结构和溶液研究。
Front Chem. 2024 Apr 4;12:1371637. doi: 10.3389/fchem.2024.1371637. eCollection 2024.
2
Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands.含三联吡啶和PTA配体的新型水溶性铜(I)配合物的设计、合成及抗癌评估
Molecules. 2024 Feb 21;29(5):945. doi: 10.3390/molecules29050945.
3
Self-Assembly and Multifaceted Bioactivity of a Silver(I) Quinolinate Coordination Polymer.
银(I)喹啉酸盐配位聚合物的自组装和多方面的生物活性。
Inorg Chem. 2021 Oct 18;60(20):15435-15444. doi: 10.1021/acs.inorgchem.1c02110. Epub 2021 Sep 21.
4
Interaction of metallocene dichlorides with apo-human transferrin: A spectroscopic study and cytotoxic activity against human cancer cell lines.茂金属二氯化物与人脱铁转铁蛋白的相互作用:一项光谱学研究及对人癌细胞系的细胞毒性活性
Int J Mol Biol (Edmond). 2020;5(3):79-109. Epub 2020 Jul 31.
5
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.从肿瘤为中心的角度探讨过渡金属配合物和光动力疗法:TLD1433 开发中的挑战、机遇和亮点。
Chem Rev. 2019 Jan 23;119(2):797-828. doi: 10.1021/acs.chemrev.8b00211. Epub 2018 Oct 8.
6
Spectroscopic Study of the Interactions of Ruthenium-Ketoconazole Complexes of Known Antiparasitic Activity with Human Serum Albumin and Apotransferrin.已知具有抗寄生虫活性的钌-酮康唑配合物与人血清白蛋白和脱铁转铁蛋白相互作用的光谱研究
J Mex Chem Soc. 2013;57(3):169-174.